No one disputes the therapeutic value of Vertex Pharmaceuticals’ triplet drug Trikafta for cystic fibrosis—not even the cost watchdogs at the Institute for Clinical ...

Scientists at Rutgers University say they've developed a smart drug delivery system that fights inflammation at the site of spinal cord injuries—paving the way for i...

Saying that a global pandemic is having a negative effect on people’s health seems obvious. However, along with direct cases of COVID-19, there is concern that tha...

When Bristol Myers Squibb this weekend unveiled a new trial win for an Opdivo combo in kidney cancer, industry watchers’ knee-jerk reaction was to compare the result...

In the earliest days of the COVID-19 pandemic, a suite of drugmakers looked to monoclonal antibodies to fight the immune system overreaction seen in severe patients....

Proven to be effective Copper Clothing fabric has been shown to be effective against Bovine Coronavirus (part of the same coronavirus family as MERS, SARS, and COV...

Novartis is aiming its new eye drug Beovu, a challenger to Regeneron's Eylea, at another of its rival's key markets. And amid a raft of safety concerns, it's being v...

Pfizer has made billions on its best-selling vaccine, Prevnar 13, but it's meanwhile advancing several phase 3 candidates to follow that product and b...

With the blasé millennial declaration “I’m So Done,” Agile Therapeutics launches a platform for women to discuss and decide which contraceptive method is best for th...

Two German biotechs, BioNTech and CureVac, have been at the cutting edge of the hunt for a COVID-19 vaccine—a time-consuming and costly process. In order to get both...